Advanced search×

Mitro-aortic infective endocarditis produced by Erysipelothrix rhusiopathiae: case report and review of the literature.

Ibrahim M Nassar, Ramiro de la Llana, Pilar Garrido, and Rafael Martinez-Sanz

J Heart Valve Dis 14(3):320-4 (2005) PMID 15974525

Endocarditis produced by Erysipelothrix rhusiopathiae is an uncommon disease in humans. This bacterial species is found worldwide as a commensal or a pathogen in many animals. Infection in humans is usually due to occupational exposure. The case is reported of a 43-year-old male parrot breeder with native aortic and mitral valve endocarditis and NYHA class II heart failure at six months after wound infection. The patient was discharged after six weeks' treatment with intravenous penicillin G and replacement of the mitral and aortic valves due to severe regurgitation. At one year after surgery the patient was asymptomatic and infection-free.

Version: za2963e q8za9 q8zba q8zce q8zd5 q8zea q8zf9 q8zg7

Similar articles you may find interesting…

  1. Neurologic Complications of Infective Endocarditis: Risk Factors, Outcome, and Impact of Cardiac Surgery: A Multicenter Observational Study.
    Emilio García-Cabrera, Nuria Fernández-Hidalgo, and on behalf of the Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases (SAEI) and the Spanish Network for Research in Infectious Diseases (REIPI)

    Circulation (2013) PMID 23648777

    Moderate-severe ischemic stroke and brain hemorrhage were found to have a significant negative impact on the outcome of IE. Early, appropriate antimicrobial treatment is critical, and transitory discontinuation of anticoagulant therapy should be considered....
  2. Double valve replacement and reconstruction of the intervalvular fibrous body in patients with active infective endocarditis.
    Piroze M Davierwala, Christian Binner, and Friedrich W Mohr

    Eur J Cardiothorac Surg (2013) PMID 23644706

    Double valve replacement with reconstruction of the intervalvular fibrous body for infective endocarditis is a complex, technically challenging operation associated with high perioperative morbidity and mortality. Nevertheless, being the only option available for such complex disease, it should be p...
  3. Contemporary Drug Treatment of Infective Endocarditis.
    Marwa A Sabe, Nabin K Shrestha, and Venu Menon

    Am J Cardiovasc Drugs (2013) PMID 23640269

    We discuss the recommended antibiotic regimens for the most common causes of IE as indicated by the American Heart Association and European Society of Cardiology. In 2008, the ACC/AHA published guideline updates on the treatment of valvular heart disease, which included a focused update on endocardi...